Loading company…
ID 221286043 · FY 2018–2023 · 6 years
Subsidiary of ბ და ნ ინვესტ (100.0%)
საქმიანობის სფერო ჯანდაცვის სხვა საქმიანობები
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 99.9% | 100.0% | 100.0% | 100.0% | 100.0% | 96.0% |
| EBITDA Margin | 59.4% | 45.2% | 14.9% | 56.4% | 50.5% | -8.6% |
| EBITDAR | 745 | 610 | 59 | 398 | 600 | -12 |
| EBITDAR Margin | 59.4% | 45.3% | 15.2% | 56.6% | 50.5% | -1.2% |
| EBIT Margin | 58.3% | 44.4% | 13.4% | 55.5% | 50.1% | -38.2% |
| Net Profit Margin | 51.0% | 38.1% | -14.6% | 45.7% | 39.8% | -45.9% |
| Operating Expense % of Sales | 40.4% | 54.8% | 85.1% | 43.6% | 49.5% | 104.6% |
| Returns | ||||||
| Return on Assets (ROA) | 14.3% | 11.0% | -1.2% | 6.6% | 9.2% | -8.9% |
| Return on Equity (ROE) | 18.3% | 12.8% | -1.4% | 7.5% | 10.0% | -10.5% |
| ROIC [EBIT / Invested Capital] | 17.0% | 13.2% | 1.1% | 8.7% | 12.3% | -7.6% |
| Leverage & liquidity | ||||||
| Debt-to-Assets | 20.5% | 13.5% | 13.8% | 9.4% | 5.8% | 13.2% |
| Debt-to-Equity | 0.26x | 0.16x | 0.16x | 0.11x | 0.06x | 0.15x |
| Debt-to-EBITDA | 1.23x | 1.04x | 10.91x | 1.15x | 0.50x | N/A |
| Equity-to-Assets | 78.2% | 85.7% | 85.9% | 88.2% | 92.6% | 85.1% |
| Net Debt | 799 | 505 | 609 | 211 | 83 | 648 |
| Cash & Equivalents | 116 | 128 | 24 | 245 | 217 | 16 |
| Total Debt | 915 | 633 | 633 | 456 | 300 | 664 |
| Efficiency & working capital | ||||||
| Inventory Turnover | N/A | N/A | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover | 14.75x | 9.66x | 9.40x | 14.12x | 11.36x | 14.95x |
| Days Sales Outstanding (DSO) | 24.7 | 37.8 | 38.8 | 25.8 | 32.1 | 24.4 |
| Payables Turnover | N/A | N/A | N/A | N/A | N/A | 0.77x |
| Days Payable Outstanding (DPO) | N/A | N/A | N/A | N/A | N/A | 472.4 |
| Cash Conversion Cycle | 24.7 days | 37.8 days | 38.8 days | 25.8 days | 32.1 days | -448.0 days |
| Asset Turnover | 0.28x | 0.29x | 0.08x | 0.15x | 0.23x | 0.19x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | 70 | 12 | 4 | 220 | -28 | -201 |
| Free Cash Flow (OCF − Capex proxy) | 70 | 12 | -104 | 220 | -28 | -201 |
| Cash Conversion (OCF / EBITDA) | 9.5% | 2.0% | 6.8% | 55.4% | -4.7% | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).